Metabolic Control Articles & Analysis
5 news found
About Faeth Faeth Therapeutics is a cancer metabolism company developing clinically-tested nutrition control, therapeutics, and digital tools for the treatment of cancer. Founded in 2019 by leading researchers in Europe and the United States and backed by leading investors, the company is pioneering its work in cancer metabolism to support a ...
ByxCures
AMPK regulates cellular events, including cell growth, metabolic reprogramming, and autophagy. AMPK has emerged as a potential therapeutic target for metabolic diseases such as type 2 diabetes and cancer. ...
With two-year follow-up from 34 patients in the per-protocol (PP) population, the study observed no long-term adverse events from Revita in patients with poorly controlled diabetes on oral glucose-lowering medications. In the cohort followed through two years, HbA1c was observed to be statistically significantly reduced at all time points, as were broader measures of ...
The product, Modius, claims to stimulate the part of the brain that controls fat storage and metabolism. The company, Modius Health, was set up by neuroscientist Dr Jason McKeown from Portglenone, County Antrim in 2013. ...
“The Revita T2Di pivotal study addresses a significant challenge in today's treatment of type 2 diabetes, which is that most patients on insulin are still not able to achieve adequate glycemic (blood sugar) control. There is increasing evidence for the role of the gut in metabolic diseases, and data from earlier clinical studies of Revita DMR is ...